top of page


Jenny Epstein is a respected opinion leader within the field and publishes widely in the international medical press, particularly within the areas of inflammatory bowel disease and eosinophilic oesophagitis.  She is an expert contributor to national clinical guidelines and clinical decision-making in the context of Covid19.

  • Features associated with mucosal healing and inflammation in paediatric Crohn's disease. Taylor H, Serrano-Contreras J, McDonald J, Epstein J, Fell J, Seoane R, Li J, Marchesi J, Hart A. Aliment Pharmacol Ther. 2020 Sep 14.   

  • Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel. Hansen R, Meade S, Beattie RM, Auth MK, Croft N, Davies P, Devadason D, Doherty C, Epstein J, Howarth L, Kiparissi F, Muhammed R, Shivamurthy V, Spray C, Stanton MP, Torrente F, Urs A, Wilson D, Irving PM, Samaan M, Kammermeier J. Gut. 2020 Sep 1.

  • Impact of COVID-19 on diagnosis and management of paediatric inflammatorybowel disease during lockdown: a UK nationwide study. Ashton JJ, Kammermeier J, Spray C, Russell RK, Hansen R, Howarth LJ, Torrente F, Deb P, Renji E, Muhammed R, Paul T, Kiparissi F, Epstein J, Lawson M, Hope B, Zamvar V, Narula P, Kadir A, Devadason D, Bhavsar H, Beattie RM.  Archives of Disease in Childhood 2020 Jul 30. 

  • Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J. Br J Clin Pharmacol 2018 Apr;84(4):694-699.

  • Oral iron treatment response and predictors in anaemic adolescents and adults with IBD. Rampton DS, Goodhand JR, Joshi NM, Karim AB, Koodun Y, Barakat FM, Macken L, Ward DG, Iqbal TH, Epstein J, Fell JM, Sanderson IR J Crohns Colitis. 2017 Jun 1;11(6):706.

  • Assessing the colonic microbiota in children: Effects of sample site and bowel preparation. Shaw AG, Black N, Rushd A, Sim K, Randell P, Kroll JS, Epstein J. J Pediatr Gastroenterol Nutr. 2017 Feb; 64(2):230-237.

  • Local chemokine profiling in eosinophilic esophagitis: The synthetic absorptive matrix test. Minshall E, Patel H, Francis N, Hansel TT, Warner JO, Boyle RJ, Fell J, Epstein J. Pediatr Allergy Immunol. 2017 Feb; 28(1):100-102.

  • Chronic recurrent multifocal osteomyelitis and inflammatory bowel disease: UK case series and literature review. Audu G, Nikaki K, Crespi D, Spray C, Epstein J. J Pediatr Gastroenterol Nutr 2015 May; 60(5):586-591.

  • Recent advances in the pathophysiology and management of eosinophilic oesophagitis. Epstein J, Warner JO. Clin Exp Allergy. 2014 Jun;44(6):802-12.

  • Do children with IBD really respond better than adults to thiopurines? Goodhand J, Rao A, Kotta S, Wahed M, Croft N, Sanderson I, Epstein J, Rampton D. J. Paediatr Gastroenterol Nutr 2011 Jun; 52(6); 702-7.

  • Curcumin as a therapeutic agent: The evidence from in vitro, animal and human    studies. Epstein J, Sanderson I, MacDonald T. Br J Nutr. 2010 Jun; 103(11):1545-57.

  • Curcumin  suppresses  p38 MAPK activation,  reduces  IL-1β and  MMP-3,  and enhances IL-10 expression in the mucosa of children and adults with inflammatory bowel disease. Epstein J, Docena G, MacDonald T, Sanderson I.  Br J Nutr 2009 Nov 2:1-9.

bottom of page